https://www.clarevia.com/press_post_type/venture-investors-health-fund-talks-latest-investments/2025-12-12T14:04:00-06:00https://www.clarevia.com/press_post_type/visana-health-raises-24m-series-a-to-scale-virtual-first-womens-health-clinic/2025-12-12T14:08:34-06:00https://www.clarevia.com/press_post_type/ann-arbor-vc-firm-launches-80m-fund-focusing-on-university-spinouts/2025-12-12T14:10:08-06:00https://www.clarevia.com/press_post_type/exclusive-venture-investors-health-fund-raises-80m/2025-12-12T14:11:10-06:00https://www.clarevia.com/press_post_type/vanguards-of-health-care-histosonics-fights-cancer-with-ultrasound/2025-12-12T14:12:00-06:00https://www.clarevia.com/press_post_type/bezos-backed-group-acquires-um-spinout-company-in-2-25b-private-deal/2025-12-12T14:12:56-06:00https://www.clarevia.com/press_post_type/liver-tumor-therapy-company-histosonics-valued-at-2-25-billion-in-sale/2025-12-12T14:41:20-06:00https://www.clarevia.com/press_post_type/histosonics-announces-2-25b-acquisition-by-consortium-of-top-tier-investors/2025-12-12T14:14:49-06:00https://www.clarevia.com/press_post_type/fda-grants-breakthrough-device-status-for-elucents-envisio-x1-system/2025-12-12T14:16:22-06:00https://www.clarevia.com/press_post_type/9-federally-funded-scientific-breakthroughs-that-changed-everything/2025-12-12T14:19:10-06:00https://www.clarevia.com/press_post_type/elucent-medical-receives-fda-breakthrough-device-designation/2025-12-12T14:54:42-06:00https://www.clarevia.com/press_post_type/invenra-launches-t-body-trispecific-platform-to-advance-next-generation/2025-12-12T14:22:03-06:00https://www.clarevia.com/press_post_type/histosonics-secures-first-insurance-coverage-for-histotripsy-system/2025-12-12T14:25:46-06:00https://www.clarevia.com/press_post_type/histosonics-histotripsy-system-demonstrates-90-local-tumor-control/2025-12-12T14:26:54-06:00https://www.clarevia.com/press_post_type/rivermark-medical-announces-first-patient-enrolled-in-rapid-iii-clinical/2025-12-12T14:28:05-06:00https://www.clarevia.com/press_post_type/2115/2025-12-12T14:40:27-06:00https://www.clarevia.com/press_post_type/why-these-10-medical-device-makers-are-the-most-innovative/2025-12-12T14:31:22-06:00https://www.clarevia.com/press_post_type/this-company-treats-liver-tumors-by-liquefying-them-with-ultrasound-waves/2025-12-12T14:32:33-06:00https://www.clarevia.com/press_post_type/nvca-announces-histosonics-as-2025-startup-innovator/2025-12-12T14:33:46-06:00https://www.clarevia.com/press_post_type/blue-cross-blue-shield-of-massachusetts-adds-new-virtual-care/2025-12-12T14:36:20-06:00https://www.clarevia.com/press_post_type/invenra-and-orion-announce-discovery-service-and-commercial-license/2025-12-12T14:37:29-06:00https://www.clarevia.com/press_post_type/trinity-capital-inc-provides-30-million-in-growth-capital-to-elucent-medical/2025-12-12T14:38:16-06:00https://www.clarevia.com/press_post_type/he-came-to-michigan-for-the-auto-industry-now-he-builds-billion-dollar-companies/2025-12-15T13:26:40-06:00https://www.clarevia.com/press_post_type/vialase-announces-first-patient-treated-in-ide-clinical-trial-evaluating-its-femtosecond-laser-trabeculotomy-for-open-angle-glaucoma/2025-12-15T13:27:25-06:00https://www.clarevia.com/press_post_type/elephas-biosciences-raises-40m-to-accelerate-commercialization-of-its-live-tumor-profiling-platform/2025-12-15T15:07:10-06:00https://www.clarevia.com/press_post_type/histosonics-raises-250m-led-by-new-owners/2026-01-07T05:27:17-06:00https://www.clarevia.com/press_post_type/michigan-venture-capital-association-showcases-record-breaking-achievements-at-2025-awards/2026-01-07T05:49:16-06:00https://www.clarevia.com/press_post_type/first-cancer-patient-screened-using-elphas-live-platform-at-indna-life-sciences-in-india/2026-01-07T05:53:12-06:00https://www.clarevia.com/press_post_type/otsuka-announces-fda-acceptance-and-priority-review-of-new-drug-application-for-centanafadine-for-the-treatment-of-adhd-in-children-adolescents-and-adults/2026-02-09T09:31:36-06:00https://www.clarevia.com/press_post_type/iterion-therapeutics-announces-first-patient-dosed-in-clinical-study-of-tegavivint/2026-03-09T08:49:21-05:00https://www.clarevia.com/press_post_type/time100-health-2026-zhen-xu-of-histosonics/2026-03-09T08:51:24-05:00